Oz Biosciences CRE Genome Editing mRNA Modified

Oz Biosciences CRE Genome Editing mRNA Modified

CRE mRNA has been designed to produce high expression level of CRE recombinase fused to a nuclear localisation sequence (NLS). CRE mRNA encodes for the CRE recombinase is a type I topoisomerase from bacteriophage P1 that catalyses the site-specific recombination of DNA between two loxP sites. OZ Biosciences mRNAs are produced by in vitro transcription and stabilised at the 5' end by modified nucleotides capping (Cap1). These mature mRNAs contain a poly(A) tail at the 3' end and are also optimised to yield improved stability and performance.

Ready-to-use stabilised CRE mRNA

Concentration: 1.0mg/mL in 1mM sodium citrate, pH 6.4

MRNA33 does not bear any additional nucleotide modifications

MRNA32 is modified with 5-methoxyuridine (5moU) to reduce innate immune responses

MRNA26 is modified with N1-methyl-pseudouridine (N1-mψ) to reduce innate immune response

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Manufacturer Price Quantity
3075027 Oz Biosciences CRE Genome Editing mRNA Modified OZ BIOSCIENCES
£522.86 (exc VAT) per 100UG
-
+
3075028 Oz Biosciences CRE Genome Editing mRNA Modified OZ BIOSCIENCES
Click Add to Quote for price and delivery
-
+
3075029 Oz Biosciences CRE Genome Editing mRNA Modified OZ BIOSCIENCES
£222.86 (exc VAT) per 20UG
-
+